PSMD11
26S proteasome non-ATPase regulatory subunit 11
Also known as: MGC3844, p44.5, PSD11_HUMAN, Rpn6, S9
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00231
- Gene
- PSMD11
- Ensembl
- ENSG00000108671
- Chromosome
- 17
- Canonical length
- 422 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Perinuclear theca,Principal piece
OverviewNCBI Gene
The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. This gene encodes a member of the proteasome subunit S9 family that functions as a non-ATPase subunit of the 19S regulator and is phosphorylated by AMP-activated protein kinase. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
422 residues, UniProt reviewed canonical sequence.
>O00231|PSMD11
1 MAAAAVVEFQ RAQSLLSTDR EASIDILHSI VKRDIQENDE EAVQVKEQSI LELGSLLAKT
61 GQAAELGGLL KYVRPFLNSI SKAKAARLVR SLLDLFLDME AATGQEVELC LECIEWAKSE
121 KRTFLRQALE ARLVSLYFDT KRYQEALHLG SQLLRELKKM DDKALLVEVQ LLESKTYHAL
181 SNLPKARAAL TSARTTANAI YCPPKLQATL DMQSGIIHAA EEKDWKTAYS YFYEAFEGYD
241 SIDSPKAITS LKYMLLCKIM LNTPEDVQAL VSGKLALRYA GRQTEALKCV AQASKNRSLA
301 DFEKALTDYR AELRDDPIIS THLAKLYDNL LEQNLIRVIE PFSRVQIEHI SSLIKLSKAD
361 VERKLSQMIL DKKFHGILDQ GEGVLIIFDE PPVDKTYEAA LETIQNMSKV VDSLYNKAKK
421 LTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSMD11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 97 nTPM
- tongue: 55 nTPM
- esophagus: 37 nTPM
- tonsil: 37 nTPM
- heart muscle: 36 nTPM
- thymus: 36 nTPM
Single-cell type
- syncytiotrophoblasts: 411 nCPM
- esophageal apical cells: 235 nCPM
- early spermatids: 228 nCPM
- cytotrophoblasts: 221 nCPM
- late primary spermatocytes: 221 nCPM
- migrating cytotrophoblasts: 197 nCPM
Immune cell
- T-reg: 52 nTPM
- basophil: 48 nTPM
- NK-cell: 48 nTPM
- myeloid DC: 47 nTPM
- non-classical monocyte: 46 nTPM
- total PBMC: 46 nTPM
Brain region
- white matter: 57 nTPM
- cerebral cortex: 55 nTPM
- pons: 53 nTPM
- medulla oblongata: 49 nTPM
- hippocampal formation: 48 nTPM
- thalamus: 48 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PSMD11.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 59 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Short stature
- PSMD11-associated obesity and neurodevelopmental disorder
- PSMD11-Related Disorders
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.16
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.61
- DepMap mean gene effect
- -1.91
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- proteasome assembly
- proteasome-mediated ubiquitin-dependent protein catabolic process
- stem cell differentiation
- ubiquitin-dependent protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Proteasome component (PCI) domain
- Tetratricopeptide-like helical domain superfamily
- Winged helix DNA-binding domain superfamily
- 26S Proteasome and COP9 Signalosome Components
- PCI domain
- 26S proteasome regulatory subunit Rpn6, N-terminal
- 6S proteasome subunit Rpn6, C-terminal helix domain
- 26S proteasome regulatory subunit RPN6 N-terminal domain
- 26S proteasome subunit RPN6 C-terminal helix domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSMD11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSMD11 as an antibody target. Whether an autoantibody or antibody against PSMD11 could matter depends on whether native PSMD11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSMD11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PSMD11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...